Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Patol Fiziol Eksp Ter ; (3): 31-3, 1994.
Artigo em Russo | MEDLINE | ID: mdl-7824341

RESUMO

The experiments on 18 isolated albino rat hearts have shown that sodium nucleinate exerts a protective action on the occurrence of reperfusion ventricular arrhythmias. Sodium nucleinate was given orally in a daily dose of 50/kg for 2 weeks. The agent reduced the blood concentrations of medium-weight molecular peptides, which may be regarded as the liquidation of a factor predisposing to arrhythmias. Other possible mechanisms responsible for the antiarrhythmic activity of sodium nucleinate, which are adaptable to the immunomodulating and membranoprotective properties of the drug, as well as to its ability to enhance intracellular metabolism are also discussed in the paper.


Assuntos
Adjuvantes Imunológicos/farmacologia , Arritmias Cardíacas/prevenção & controle , Ácidos Nucleicos/farmacologia , Peptídeos/sangue , Traumatismo por Reperfusão/prevenção & controle , Disfunção Ventricular/prevenção & controle , Animais , Arritmias Cardíacas/sangue , Técnicas In Vitro , Peso Molecular , Ratos , Traumatismo por Reperfusão/sangue , Disfunção Ventricular/sangue
3.
Kardiologiia ; 32(3): 52-5, 1992 Mar.
Artigo em Russo | MEDLINE | ID: mdl-1383591

RESUMO

The clinicoimmunological study revealed immunocompetence dysfunction in 28 patients with idiopathic ventricular arrhythmias resistant to ritmilen. After sodium nucleinate immunomodulation, ritmilen therapy proved to be beneficial in 46.6% of the patients. A positive result was obtained only in the patients who showed the same or close values as in healthy individuals. The comparison has led to the conclusion that idiopathic ventricular arrhythmias are directly related to immune dysfunction and to the recommendation that sodium nucleinate should be used in the multimodality therapy of the arrhythmias.


Assuntos
Linfócitos B/imunologia , Complexos Cardíacos Prematuros/imunologia , Linfócitos T/imunologia , Adjuvantes Imunológicos , Adulto , Linfócitos B/efeitos dos fármacos , Complexos Cardíacos Prematuros/tratamento farmacológico , Disopiramida/administração & dosagem , Quimioterapia Combinada , Feminino , Humanos , Contagem de Leucócitos/efeitos dos fármacos , Masculino , Pessoa de Meia-Idade , Ácidos Nucleicos/administração & dosagem , Formação de Roseta , Linfócitos T/efeitos dos fármacos
6.
Vrach Delo ; (8): 47-9, 1991 Aug.
Artigo em Russo | MEDLINE | ID: mdl-1949732

RESUMO

A study is presented of 32 patients (18 men, 14 women; age from 16 to 38 years) with WPW syndrome. Immunological investigations revealed characteristic of WPW syndrome phenotypic peculiarities with characteristic changes of the immune status, allowed to evaluate the mechanism of formation of Kent's bundle and to discuss the problem of primary prophylaxis by means of immunoactive agents.


Assuntos
Síndrome de Wolff-Parkinson-White/imunologia , Adolescente , Adulto , Complexo Antígeno-Anticorpo/sangue , Linfócitos B/imunologia , Feminino , Humanos , Imunoglobulinas/análise , Masculino , Fagocitose/imunologia , Linfócitos T/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA